🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested
This phase II trial studies how well apalutamide and gonadotropin-releasing...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-10-13
Trial ID
NCT03279250
The purpose of this study is to evaluate the effect of timing of food intak...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01575587
This Phase II study has been designed to evaluate the anti-tumor effects of...
Status
Terminated
Location
Prostate Oncology Specialists, Inc.
Start Date
2012-12
Trial ID
NCT01681433
Treatments Being Tested
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
This phase II trial studies how well finite androgen ablation with or witho...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2013-02-05
Trial ID
NCT01786265
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology LLC
Start Date
2021-03-18
Trial ID
NCT04691804
This is a phase II randomized study of standard of care (SOC) neo-adjuvant ...
Status
Active Not Recruiting
Location
Indiana University
Start Date
2021-10-13
Trial ID
NCT05137262
Treatments Being Tested